{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:41:52Z","timestamp":1772811712868,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1990,12,1]],"date-time":"1990-12-01T00:00:00Z","timestamp":660009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":9132,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[1990,12]]},"DOI":"10.1111\/1523-1747.ep12875523","type":"journal-article","created":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T05:47:34Z","timestamp":1089870454000},"page":"S198-S205","source":"Crossref","is-referenced-by-count":117,"special_numbering":"S","title":["Photochemotherapy Alone or Combined with Interferon Alpha-2a in the Treatment of Cutaneous T-Cell Lymphoma"],"prefix":"10.1016","volume":"95","author":[{"suffix":"Jr.","given":"Henry H.","family":"Roenigk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Kuzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra P.","family":"Skoutelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Springer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Caro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Gilyon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daina","family":"Variakojis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Paul A.","family":"Bunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven T.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/1523-1747.ep12875523_bb0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00005792-197201000-00004","article-title":"Mycosis fungoides: survival, prognostic features, response to therapy and autopsy findings","volume":"51","author":"Epstein","year":"1972","journal-title":"Medicine"},{"key":"10.1111\/1523-1747.ep12875523_bb0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1182\/blood.V57.2.261.261","article-title":"Cutaneous T-cell lymphoma: characterization by monoclonal antibodies","volume":"57","author":"Kung","year":"1981","journal-title":"Blood"},{"key":"10.1111\/1523-1747.ep12875523_bb0020","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1172\/JCI108585","article-title":"The Sezary syndrome: a malignant proliferation of helper T-cells","volume":"58","author":"Broder","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1111\/1523-1747.ep12875523_bb0025","first-page":"681","article-title":"A 10-year experience with topical mechlorethamine for mycosis fungoides: comparnies with patients treated by total skin electron beam radiation therapy","volume":"63","author":"Vonderheid","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1111\/1523-1747.ep12875523_bb0030","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0190-9622(85)70206-X","article-title":"Photochemotherapy in cutaneous T-cell lymphoma and parapsoriasis en plaques","volume":"13","author":"Rosenbaum","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/1523-1747.ep12875523_bb0035","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1200\/JCO.1986.4.7.1094","article-title":"Combined modality treatment of cutaneous T-cell lymphomas: results of a six year follow-up","volume":"4","author":"Winkler","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1111\/1523-1747.ep12875523_bb0040","unstructured":"In: Moosa AR Robson MC Schimpff SC (eds.)Williams and Wilkins, Baltimorein press J.A Levi S.T Rosen Cutaneous T-cell lymphomas Comprehensive Textbook of Oncology"},{"key":"10.1111\/1523-1747.ep12875523_bb0045","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.1988.6.7.1177","article-title":"Combined modality therapy for tumor stage mycosis fungoides: results of a 10 year follow up","volume":"6","author":"Hallahan","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1111\/1523-1747.ep12875523_bb0050","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-101-4-484","article-title":"Recombinant leukocyte A Interferon: an active agent in advanced cutaneous T-cell lymphomas","volume":"101","author":"Bunn","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1111\/1523-1747.ep12875523_bb0055","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/1097-0142(19860415)57:8+<1689::AID-CNCR2820571311>3.0.CO;2-M","article-title":"The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas","volume":"57","author":"Bunn","year":"1986","journal-title":"Cancer"},{"key":"10.1111\/1523-1747.ep12875523_bb0060","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(89)70049-9","article-title":"Interferon alfa-2a in the treatment of cutaneous T-cell lymphoma","volume":"20","author":"Olsen","year":"1989","journal-title":"J Acad Dermatol"},{"key":"10.1111\/1523-1747.ep12875523_bb0065","first-page":"337","article-title":"Alpha recombinant interferon in the treatment of mycosis fungoides (MF)","volume":"72","author":"Tura","year":"1987","journal-title":"Haematologica"},{"key":"10.1111\/1523-1747.ep12875523_bb0070","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/archderm.1987.01660300079016","article-title":"Recombinant interferon alpha-2b in plaque phase mycosis fungoides","volume":"123","author":"Vonderheid","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1111\/1523-1747.ep12875523_bb0075","first-page":"189","article-title":"Recombinant leukocyte A interferon (Ifn-rA) as initial therapy in mycosis fungoides (MF) and Sezary syndrome (SS) (abstr)","volume":"6","author":"Corelli","year":"1987","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1111\/1523-1747.ep12875523_bb0080","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/1097-0142(197608)38:2<683::AID-CNCR2820380210>3.0.CO;2-V","article-title":"Oral methoxsalen photochemotherapy of mycosis fungoides","volume":"38","author":"Gilchrest","year":"1976","journal-title":"Cancer"},{"key":"10.1111\/1523-1747.ep12875523_bb0085","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archderm.1977.01640080049003","article-title":"Photochemotherapy for mycosis fungoides","volume":"113","author":"Roenigk","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1111\/1523-1747.ep12875523_bb0090","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0025-6196(12)61492-X","article-title":"Treatment of parapsoriasis, and mycosis fungoides: the role of psoralen and long-wave ultraviolet light A (PUVA)","volume":"59","author":"Powell","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/1523-1747.ep12875523_bb0095","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-4362.1983.tb02190.x","article-title":"The management of minimal extent mycosis funcoides","volume":"22","author":"Rotstein","year":"1983","journal-title":"Intern J Dermatol"},{"key":"10.1111\/1523-1747.ep12875523_bb0100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archderm.1979.04010010022007","article-title":"Photochemotherapy for mycosis fungoides. A clinical and histological study","volume":"115","author":"Lowe","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1111\/1523-1747.ep12875523_bb0105","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2230.1980.tb01725.x","article-title":"Histological changes observed in the skin of patients with mycosis fungoides receiving photochemotherapy","volume":"5","author":"Mackie","year":"1980","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/1523-1747.ep12875523_bb0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00000372-197901010-00002","article-title":"The patch stage of mycosis fungoides. Criteria for histological diagnosis","volume":"1","author":"Sanchez","year":"1979","journal-title":"Am J Dermatopathol"},{"key":"10.1111\/1523-1747.ep12875523_bb0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/1097-0142(19800101)45:1<137::AID-CNCR2820450124>3.0.CO;2-K","article-title":"Dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides","volume":"45","author":"Scheffer","year":"1980","journal-title":"Cancer"},{"key":"10.1111\/1523-1747.ep12875523_bb0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/1097-0142(19810115)47:2<351::AID-CNCR2820470224>3.0.CO;2-4","article-title":"Lymph node biopsy in mycosis fungoides","volume":"47","author":"Colby","year":"1981","journal-title":"Cancer"},{"key":"10.1111\/1523-1747.ep12875523_bb0125","first-page":"725","article-title":"Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas","volume":"63","author":"Bunn","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1111\/1523-1747.ep12875523_bb0130","first-page":"1354","article-title":"Quantitative prediction of drug toxicity in humans from toxicology in small and large animals","volume":"35","author":"Goldsmith","year":"1975","journal-title":"Cancer Res"},{"key":"10.1111\/1523-1747.ep12875523_bb0135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(80)92937-2","article-title":"Photochemotherapy in mycosis fungoides. A study of 73 patients","volume":"2","author":"Vella-Briffa","year":"1980","journal-title":"Lancet"},{"key":"10.1111\/1523-1747.ep12875523_bb0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2340\/00015555614751","article-title":"Photochemotherapy (PUVA) in pretumor stage of mycosis fungoides: a report from the Scandinavia mycosis fungoides study group","volume":"61","author":"Molin","year":"1980","journal-title":"Acta Dermato Venereol"},{"key":"10.1111\/1523-1747.ep12875523_bb0145","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2230.1981.tb02372.x","article-title":"Photochemotherapy in the treatment of psoriasis and mycosis fungoides","volume":"6","author":"Warin","year":"1981","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/1523-1747.ep12875523_bb0150","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0190-9622(84)70030-2","article-title":"Photochemotherapy for cutaneous T-cell lymphoma. A follow up study","volume":"10","author":"Honigsmann","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/1523-1747.ep12875523_bb0155","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0190-9622(81)70041-0","article-title":"PUVA treatment of erythrodermic and plaque type mycosis fungoides","volume":"4","author":"Abel","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/1523-1747.ep12875523_bb0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/jnci\/82.3.203","article-title":"Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma","volume":"82","author":"Kuze","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/1523-1747.ep12875523_bb0165","doi-asserted-by":"crossref","first-page":"472","DOI":"10.7326\/0003-4819-91-3-472","article-title":"Interferons: rationale for clinical trials in neoplastic disease","volume":"91","author":"Borden","year":"1979","journal-title":"Ann Intern Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X9091221V?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X9091221V?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T21:45:51Z","timestamp":1705182351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X9091221V"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1990,12]]}},"alternative-id":["S0022202X9091221V"],"URL":"https:\/\/doi.org\/10.1111\/1523-1747.ep12875523","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[1990,12]]}}}